Drug Shortage Report for JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE
Report ID | 4434 |
Drug Identification Number | 02418258 |
Brand name | JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE |
Common or Proper name | Irbesartan Hydrochlorothiazide Tablets |
Company Name | JAMP PHARMA CORPORATION |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE IRBESARTAN |
Strength(s) | 25MG 300MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 28 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2016-09-15 |
Estimated end date | 2017-08-31 |
Actual end date | 2017-04-28 |
Shortage status | Resolved |
Updated date | 2017-08-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2017-08-08 | French | Compare |
v6 | 2017-08-08 | English | Compare |
v5 | 2017-07-12 | French | Compare |
v4 | 2017-07-12 | English | Compare |
v3 | 2017-04-29 | English | Compare |
v2 | 2017-03-27 | French | Compare |
v1 | 2017-03-27 | English | Compare |
Showing 1 to 7 of 7